…molecules have yet to be approved as clinical therapeutics for the microbiome, live bacterial therapeutics (LBT) have been developed to achieve beneficial clinical outcomes. A relatively crude but effective approach…

…protein subunit vaccine to the market,” said Stanley Erck, President and Chief Executive Officer at Novavax. “With clinical data from our trials showing strong efficacy against Variants of Concern and…

eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, has opened a subsidiary, eTheRNA Asia, with offices located in the Sheung Wan area…

…Research will provide clinical laboratory screening and safety testing for NIAID-supported clinical trials within the infectious disease area. “We are pleased to be recognised for our depth and breadth of…

…Clinical Research Organisation with specialist expertise in clinical pharmacology, oncology and rare diseases. Prior to this, she served as an Executive Officer and Senior Vice-President of Parexel, a US based,…

…even those that have already metastasised. Once translated to an early phase clinical trial, 108600 has the potential to improve survival and quality of life for patients diagnosed with triple…

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel medicines that can prevent life threatening infections, has released data from its recent Phase IIb clinical trial….

…Clinical Trials: The Quick Reference Guide 3. Decentralised Clinical Trials Risk Assessment Considerations 4. Decentralised Clinical Trials Data Flow Maps “With the DCT Data Flow Maps project, ACRO’s Decentralized Clinical…

…Hill, Chief Scientific Officer for England; Senior Responsible Officer for Genomics, NHS England; Dr Richard Scott, Clinical Director, Genomics England; and David Atkins PhD, Chief Executive Officer, Congenica. Download here….

…treatment and vaccination against the virus took priority. Meanwhile, phases of clinical trials and drug approval became topics of conversation. Public attention on life sciences benefitted biotech financially. Previously uninterested…